Reconciling Decision Models With the Real World
- 1 January 1999
- journal article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 15 (5), 481-493
- https://doi.org/10.2165/00019053-199915050-00006
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clinical Trials and External ValidityValue in Health, 1998
- Health and Economic Outcomes Modeling Practices: A Suggested FrameworkValue in Health, 1998
- Reassessing the relevance of pharmacoeconomic analyses in formulary decisions.PharmacoEconomics, 1998
- X. The economic cost of ESRD, vascular access procedures, and medicare spending for alternative modalities of treatmentAmerican Journal of Kidney Diseases, 1997
- A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemiaThe American Journal of Cardiology, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsThe New England Journal of Medicine, 1996
- Cholesterol Lowering and the Use of Healthcare ResourcesCirculation, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Resurgence of Blood Transfusion Therapy in Erythropoietin Treated Hemodialysis PatientsASAIO Journal, 1995
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987